Orchestra BioMed Statistics Share Statistics Orchestra BioMed has 48.06M
shares outstanding. The number of shares has increased by 1.29%
in one year.
Shares Outstanding 48.06M Shares Change (YoY) 1.29% Shares Change (QoQ) 0.79% Owned by Institutions (%) 49.54% Shares Floating 33.45M Failed to Deliver (FTD) Shares 14,980 FTD / Avg. Volume 4.99%
Short Selling Information The latest short interest is 558.82K, so 1.46% of the outstanding
shares have been sold short.
Short Interest 558.82K Short % of Shares Out 1.46% Short % of Float 2.99% Short Ratio (days to cover) 3.84
Valuation Ratios The PE ratio is -2.41 and the forward
PE ratio is -1.53.
Orchestra BioMed's PEG ratio is
-0.2.
PE Ratio -2.41 Forward PE -1.53 PS Ratio 55.83 Forward PS 35.7 PB Ratio 4.47 P/FCF Ratio -2.9 PEG Ratio -0.2
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Orchestra BioMed.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.27,
with a Debt / Equity ratio of 0.5.
Current Ratio 4.27 Quick Ratio 4.26 Debt / Equity 0.5 Debt / EBITDA -0.26 Debt / FCF -0.33 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $37.69K Profits Per Employee $-871.77K Employee Count 70 Asset Turnover 0.03 Inventory Turnover 1.18
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -58.76% in the
last 52 weeks. The beta is 0.61, so Orchestra BioMed's
price volatility has been higher than the market average.
Beta 0.61 52-Week Price Change -58.76% 50-Day Moving Average 3.03 200-Day Moving Average 4.17 Relative Strength Index (RSI) 42.42 Average Volume (20 Days) 300,012
Income Statement In the last 12 months, Orchestra BioMed had revenue of 2.64M
and earned -61.02M
in profits. Earnings per share was -1.66.
Revenue 2.64M Gross Profit 2.43M Operating Income -64.3M Net Income -61.02M EBITDA -64.3M EBIT -64.3M Earnings Per Share (EPS) -1.66
Full Income Statement Balance Sheet The company has 22.26M in cash and 16.53M in
debt, giving a net cash position of 5.73M.
Cash & Cash Equivalents 22.26M Total Debt 16.53M Net Cash 5.73M Retained Earnings -309.88M Total Assets 59.05M Working Capital 36.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.56M
and capital expenditures -289K, giving a free cash flow of -50.85M.
Operating Cash Flow -50.56M Capital Expenditures -289K Free Cash Flow -50.85M FCF Per Share -1.38
Full Cash Flow Statement Margins Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.
Gross Margin 92.27% Operating Margin -2437.49% Pretax Margin -2313.27% Profit Margin -2313.27% EBITDA Margin -2437.49% EBIT Margin -2437.49% FCF Margin -1927.48%
